Article info
Uterine Cancer
Adjuvant Pelvic Radiation “Sandwiched” Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial
- Address correspondence and reprint requests to Marina Frimer, MD, Zucker School of Medicine at Hofstra/Northwell, 1554 Northern Blvd, Suite 5 Manhasset, NY 11030. E-mail: mfrimer{at}northwell.edu.
Citation
Adjuvant Pelvic Radiation “Sandwiched” Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial
Publication history
- Received April 5, 2018
- First published November 1, 2018.
Online issue publication
November 01, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2018 by IGCS and ESGO